Zenyth Therapeutics Overview
- Founded
-
1986
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Zenyth Therapeutics General Information
Description
Manufacturer and developer of antibody-based therapies intended to serve in the areas of inflammation and cancer. The company's antibody, therapies and receptor alpha subunit enables its users in asthma and other respiratory diseases.
Contact Information
Website
www.zenyth.com.au
Formerly Known As
Amrad Corporation Limited
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 576 Swan Street
- Richmond, Victoria 3121
- Australia
Zenyth Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|